Aprea Therapeutics, Inc. [APRE]

Source: 

Company Overview

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel synthetic lethality-based cancer therapeutics that target DNA damage response pathways. Our approach is built upon a platform of integrated discovery technologies to enrich our pipeline with novel targets in synthetic lethality and cancer treatment.